TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/24 15:45 | 8/19/24 | KPRX | Kiora Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tyle Praveen | CA | D | P | 20 | 3.96 | 0 | 5 | 999% | 5 | D | |||||||||||||||
3/2/21 17:00 | 2/28/21 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tyle Praveen | TX | O | EVP,R,D | M.d | 0 | 0.00 | 0 | 68 | 129 | 121 | D | ||||||||||||||
3/3/20 16:17 | 2/28/20 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tyle Praveen | TX | O | EVP,R,D | M.d | 0 | 0.00 | 0 | 39 | 262 | 54 | D | ||||||||||||||
3/1/19 17:19 | 2/28/19 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tyle Praveen | TX | O | EVP,R,D | M.d | 0 | 0.00 | 0 | 13 | 562 | 15 | D | ||||||||||||||
3/2/18 17:11 | 2/28/18 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tyle Praveen | TX | O | EVP,R,D | M.d | 0 | 0.00 | 0 | 3 | 2 | D | |||||||||||||||
10/30/07 21:45 | 10/26/07 | BOL | Bausch & Lomb Inc | NY | Health | OthMd | Ophthalmic Goods | Tyle Praveen | NY | O | SVP | M.d | 0 | 0.00 | 0 | 18 | 0 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |